Oral Administration of Uridine for Treatment of Bipolar Depression in Adolescents: A Magnetic Resonance Spectroscopy Study.
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Uridine (Primary)
- Indications Bipolar disorders; Bipolar I disorders; Bipolar II disorders
- Focus Biomarker; Therapeutic Use
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2011 Planned End Date changed from 1 May 2012 to 1 May 2014 as reported by ClinicalTrials.gov.
- 18 Feb 2011 Actual initiation date (May 2009) added as reported by ClinicalTrials.gov.